Cam Gallagher serves as Executive at Zentalis Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Cam Gallagher has executed 152 insider transactions totaling $22.6M, demonstrating a bearish approach to their equity position. Their most recent transaction on Nov 5, 2020 involved receiving (via award) 14,489 shares valued at $0.
Cam Gallagher currently holds 1,924,430 shares of Zentalis Pharmaceuticals, Inc. (ZNTL), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Cam Gallagher has been a net seller of ZNTL stock. They have purchased $323.9K and sold $22.3M worth of shares.
Cam Gallagher's most recent insider trade was on Nov 5, 2020, when they sold 14,489 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |